Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REOLYSIN with Paclitaxel and Carboplatin in Head and Neck Cancer
NCT00753038Phase 2Completed
- Sponsor
- Oncolytics Biotech Inc.
- Start
- Aug 2008
- Primary completion
- Jul 2011
- Modality
- Oncolytic Viruses, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pelareorep in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Oncolytics Biotech Inc.. Started Aug 2008; status: completed.
02
Drugs
pelareorep
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00753038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753038.